Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 234 * | Mon, 8/4/2014, 2:00 PM - 3:50 PM | CC-258C | |
| Subgroup Analysis and Biomarkers — Contributed Papers | |||
| Biopharmaceutical Section | |||
| Chair(s): Sharon Murray, GlaxoSmithKline | |||
| 2:05 PM | Challenges and New Approaches in Identifying Treatment Specific Subgroups That Are Commercially Viable with Binary Outcomes — Lin Li, BioStat Solutions ; Tobias Guennel, BioStat Solutions ; Scott Marshall, BioStat Solutions | ||
| 2:20 PM | Simultaneous Inference for Joint Overall and Subgroup Confirmatory Hypothesis Testing — Hui Wang, Palo Alto VA/CSPCC ; Ying Lu, Palo Alto VA CSPCC/Stanford University ; Ilana Belitskaya-Lévy, Palo Alto VA CSPCC ; Gheorghe Doros, Boston University School of Public Health ; Robert A. Lew, VA Cooperative Studies Program Coordinating Center ; Mei Chiung Shih, Stanford University School of Medicine ; Lu Tian, Stanford University | ||
| 2:35 PM | Adjusting for Misclassification in the Design and Analysis of Stratified Biomarker Clinical Trials — Susan Halabi, Duke University ; Chen-Yen Lin, Eli Lilly and Company ; Aiyi Liu, NICHD | ||
| 2:50 PM | The Plan of Enrichment Designs for Dealing with High Placebo Response — Xiangmin Zhang, University of Iowa ; Yeh-Fong Chen, FDA | ||
| 3:05 PM | Identify a Target Population for Future Clinical Trial — Aiyang Tao, Novartis ; Lihui Zhao, Northwestern University ; Lee Jen Wei , Harvard ; Achim Guettner, Novartis | ||
| 3:20 PM | Greediness Reduction Interaction Tree Algorithm for Subgroup Analysis in Clinical Trials — Yi-Fan Chen, University of Illinois at Chicago ; Lisa Weissfeld, University of Pittsburgh | ||
| 3:35 PM | A Predictive Modeling Approach to Identify Clinical Important Treatment Difference in a Subgroup: Fraternal Twins Method — Max Kuhn, Pfizer ; Birol Emir, Pfizer ; Ed Whalen, Pfizer | ||
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.